Search
-
Ipsos joins an international partnership to implement non-pharmaceutical interventions against Covid-19 in Africa
Ipsos will provide the collection and analysis of data on the impact of COVID-19, behaviours surrounding it, and control measures put in place in African countries.
-
Research during Coronavirus for services, durables and technology
Innovating in Challenging Times – Issue 2
-
Many think it’s unlikely the economy will recover quickly once COVID-19 lockdown is over
Most negative about an economic recovery in hard-hit countries except China.
-
Multi-source healthcare data
The world of pharma business insight is likely to change as it embraces a multi-data source reality.
-
More people say they’re wearing masks to protect themselves from COVID-19 since March
There’s been an increase in the number of people wearing masks in many countries.
Population Movement Tracker
Tracking travel before, during and after the coronavirus pandemic.
-
Live occupancy tracker for essential retailers
Covid-19 has had a dramatic impact on where, when and how we are able to interact with our world. For hospitals, pharmacies and ‘essential’ retailers in particular, the new social distancing guidelines have made store traffic an even more crucial data metric.
-
The Reputation Council report 2020
In this report Council members tell us how they are responding to a changing and disruptive communications landscape. Our analysis reflects the latest global reputation management challenges including; sustainability as a corporative imperative; communications planning in a disruptive environment; data sources and integration to provide strategic reputation insights and key audiences in stakeholders and influencers.
-
New tech update to help social distancing in real-time launched for retailers and public spaces
US retailers and public spaces which fall under the ‘essential’ bracket can now use technology to help manage the volume of people in a space and enforce social distancing, thanks to a new tech update by Ipsos.
-
Evolution of prostate cancer treatment gathers speed
What are the treatment options for this too-prevalent disease? And the outlook for the future as clinical outcomes evolve?